Our Capital Markets team has acted for Panmure Liberum on Optima Health plc's admission to AIM. Optima Heath is the UK's leading provider of technology enabled corporate health and wellbeing solutions.

This follows the company's demerger from Marlowe PLC, a UK leader in regulatory compliance services, where Optima Health was its occupational health division. The demerger has been implemented by way of a dividend in specie of ordinary shares in the capital of Optima Health to Marlowe shareholders, with the Optima Health ordinary shares being admitted to the AIM market.

Optima Health has an extensive network comprising four core hubs – in Manchester, Glasgow, Sheffield and Towcester – a nationwide network of 48 occupational health clinics and more than 30 mobile clinics, with services delivered by a team of in excess of 800 clinicians employed directly in the UK across a wide range of disciplines.

The team advising Panmure Liberum was led by Partner Davey Brennan, with first class support from Legal Director Sue Johnston and Associate Freddie Whittle.

Davey Brennan said: "This is a significant moment for Optima Health as it looks to capitalise on the growing occupational health market in the UK. In what have been difficult markets, it's very encouraging to see a stellar business like Optima Health choosing the UK capital markets to achieve greater visibility and access to investment in order to help it expand and maximise shareholder value. It's been a pleasure supporting the Panmure Liberum team on this fantastic transaction".

Gowling WLG's Capital Markets team is well-established with an extensive track record over many years advising issuers on a variety of markets, as well as their sponsors, financial advisers, nominated advisers and brokers, in relation to IPOs, secondary fundraises, takeovers and related public company transactions.